Wave Life Sciences WVE Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 11.3×+8.3× | 6.5×+3.6× | 2.5×+0.6× | 2.6×+1.6× | 3×+1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0.2×— | 0.2×— | —— | |
| Per Share | ||||||
| Book value per share | $2.56+142% | $3.07+103% | $0.74-30.5% | $0.85+3,269% | $1.06+438% | |
| Valuation | ||||||
| Market capitalization | $1.14B+13.0% | $3.16B+67.4% | $1.17B+9.7% | $1.06B+64.7% | $1.24B+83.3% | |
| Price / book | 2.2×-3.7× | 6.1×— | 9.4×— | 7.6×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Wave Life Sciences's ratios come from?
- Every ratio is computed from Wave Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
